Dr. Gabunia, 

As I'm sure you know, Ambassador Degnan spoke to the Minister of Environmental Protection and Agriculture earlier today and he mentioned Georgia's desire to take part in the clinical trials for Gilead's Remdesivir. 

I was in touch with a representative from Gilead Pharmaceuticals today to discuss Georgia's request to participate.  They informed me that, unfortunately, the participants for the multi-site study - which I understand the WHO is implementing - have already been selected and enrollment has completed for almost all of them.  Please see below for the additional information they provided us, though you may already have it yourself. 

Please let me know if you have any further questions. 

Information on Remdesivir

 

Gilead is working closely with global health authorities to respond to the novel coronavirus (COVID-19) outbreak through the appropriate experimental use of the investigational compound remdesivir. Our first priority is to determine the safety and efficacy of remdesivir through the six ongoing trials. We believe we can best address the need in all countries by focusing our efforts on generating data that can support regulatory approvals as quickly as possible. Given the global health impact of COVID-19, we anticipate that the data from these studies could support regulatory filings around the world, including countries that are not participating in these trials.

 

Gilead is working to establish emergency access programs in many countries, it is unfortunately not feasible to do so in every country around the world. For countries without expanded access programs and also not participating in the six ongoing studies, we suggest adopting the master protocol developed by WHO as opportunity to access investigational treatments. We are in active discussions with WHO regarding support of this study to continue to enable access to remdesivir, in a streamlined way around the world, through critically important clinical trials that will hopefully clarify whether remdesivir is safe and effective for the treatment of COVID-19.

 

Please visit https://clinicaltrials.gov/ for the latest update on Gilead clinical trials and https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments for WHO Solidarity Trial

 

To get more information you can always check https://www.gilead.com/purpose/advancing-global-health/covid-19  and can connect Gilead through coronavirus.response@gilead.com for any questions, requests etc.

Best,